FDA advisory panel to discuss J&J, Moderna booster shots this month By Reuters
[ad_1]
© Reuters. FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration(Reuters) – The U.S. Food and Drug Administration announced Friday that it would convene an advisory group of experts later in the month to consider authorizing booster doses. Moderna (NASDAQ:) Inc and Johnson & Johnson (NYSE:)’s COVID-19 vaccines.
Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]